Global Lung Cancer Screening Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Lung Cancer Screening Software market size was valued at US$ 1755 million in 2025 and is forecast to a readjusted size of US$ 5472 million by 2032 with a CAGR of 17.6% during review period.
Lung cancer screening software is medical software based on medical imaging (primarily low-dose CT) and algorithm models. It is used to automatically detect lung nodules, analyze morphological characteristics, assess malignancy risk, and assist in follow-up management. Its goal is to improve the early detection rate of lung cancer, reduce the missed diagnosis rate, and support clinical decision-making and population screening.
Upstream components mainly include medical imaging data sources (CT equipment, imaging centers), computing power and cloud infrastructure, algorithm frameworks, and data annotation resources. Downstream components primarily target hospital radiology departments, regional public health screening projects, physical examination institutions, and health management and insurance-related service scenarios.
Global Market Future Development Trends
With the increasing incidence of lung cancer and the aging population, low-dose CT screening is being included in recommended or pilot programs in more and more countries. Traditional manual image interpretation is insufficient to support large-scale screening, making efficient and replicable software solutions a necessity and driving the rapid deployment of lung cancer screening software in hospitals and regional population screening.
The market is evolving from single nodule detection to risk stratification, follow-up comparison, multi-temporal analysis, and automated reporting. Algorithm stability, cross-device generalization ability, and clinical interpretability have become core competitive advantages, elevating the value of software from an 'auxiliary tool' to a 'key node in the screening process.'
Against increasingly stringent regulatory requirements from the FDA, CE, and NMPA, compliance certification has become a market entry barrier. In the future, software will increasingly take the form of platforms, integrating with PACS, regional screening systems, and cloud services, transforming from single-point sales to long-term service revenue through subscription or pay-per-view models.
This report is a detailed and comprehensive analysis for global Lung Cancer Screening Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lung Cancer Screening Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global Lung Cancer Screening Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Lung Cancer Screening Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Lung Cancer Screening Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Lung Cancer Screening Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Lung Cancer Screening Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lung Cancer Screening Software, with revenue, gross margin, and global market share of Lung Cancer Screening Software from 2021 to 2026.
Chapter 3, the Lung Cancer Screening Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Lung Cancer Screening Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Cancer Screening Software.
Chapter 13, to describe Lung Cancer Screening Software research findings and conclusion.
Lung cancer screening software is medical software based on medical imaging (primarily low-dose CT) and algorithm models. It is used to automatically detect lung nodules, analyze morphological characteristics, assess malignancy risk, and assist in follow-up management. Its goal is to improve the early detection rate of lung cancer, reduce the missed diagnosis rate, and support clinical decision-making and population screening.
Upstream components mainly include medical imaging data sources (CT equipment, imaging centers), computing power and cloud infrastructure, algorithm frameworks, and data annotation resources. Downstream components primarily target hospital radiology departments, regional public health screening projects, physical examination institutions, and health management and insurance-related service scenarios.
Global Market Future Development Trends
With the increasing incidence of lung cancer and the aging population, low-dose CT screening is being included in recommended or pilot programs in more and more countries. Traditional manual image interpretation is insufficient to support large-scale screening, making efficient and replicable software solutions a necessity and driving the rapid deployment of lung cancer screening software in hospitals and regional population screening.
The market is evolving from single nodule detection to risk stratification, follow-up comparison, multi-temporal analysis, and automated reporting. Algorithm stability, cross-device generalization ability, and clinical interpretability have become core competitive advantages, elevating the value of software from an 'auxiliary tool' to a 'key node in the screening process.'
Against increasingly stringent regulatory requirements from the FDA, CE, and NMPA, compliance certification has become a market entry barrier. In the future, software will increasingly take the form of platforms, integrating with PACS, regional screening systems, and cloud services, transforming from single-point sales to long-term service revenue through subscription or pay-per-view models.
This report is a detailed and comprehensive analysis for global Lung Cancer Screening Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lung Cancer Screening Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global Lung Cancer Screening Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Lung Cancer Screening Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Lung Cancer Screening Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Lung Cancer Screening Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cloud-Based
- Web-Based
- Nodule Detection
- Nodule Analysis
- Full-Process Screening
- Predictive Assessment
- Standalone AI Software
- PACS/RIS Integrated Plugin
- Built-in Solution for Imaging Equipment
- Regional Screening Platform System
- Hospitals
- Medical Examination Institutions
- Public Health Screening
- Others
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems
- United Imaging Healthcare
- InferVision
- Airdoc
- VUNO
- Lunit
- Qure.ai
- Riverain Technologies
- Zebra Medical Vision
- Arterys
- Deepwise
- EverFortune AI
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Lung Cancer Screening Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lung Cancer Screening Software, with revenue, gross margin, and global market share of Lung Cancer Screening Software from 2021 to 2026.
Chapter 3, the Lung Cancer Screening Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Lung Cancer Screening Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Cancer Screening Software.
Chapter 13, to describe Lung Cancer Screening Software research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lung Cancer Screening Software by Type
1.3.1 Overview: Global Lung Cancer Screening Software Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Lung Cancer Screening Software Consumption Value Market Share by Type in 2025
1.3.3 Cloud-Based
1.3.4 Web-Based
1.4 Classification of Lung Cancer Screening Software by Screening Technologies
1.4.1 Overview: Global Lung Cancer Screening Software Market Size by Screening Technologies: 2021 Versus 2025 Versus 2032
1.4.2 Global Lung Cancer Screening Software Consumption Value Market Share by Screening Technologies in 2025
1.4.3 Nodule Detection
1.4.4 Nodule Analysis
1.4.5 Full-Process Screening
1.4.6 Predictive Assessment
1.5 Classification of Lung Cancer Screening Software by System Integration Level
1.5.1 Overview: Global Lung Cancer Screening Software Market Size by System Integration Level: 2021 Versus 2025 Versus 2032
1.5.2 Global Lung Cancer Screening Software Consumption Value Market Share by System Integration Level in 2025
1.5.3 Standalone AI Software
1.5.4 PACS/RIS Integrated Plugin
1.5.5 Built-in Solution for Imaging Equipment
1.5.6 Regional Screening Platform System
1.6 Global Lung Cancer Screening Software Market by Application
1.6.1 Overview: Global Lung Cancer Screening Software Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals
1.6.3 Medical Examination Institutions
1.6.4 Public Health Screening
1.6.5 Others
1.7 Global Lung Cancer Screening Software Market Size & Forecast
1.8 Global Lung Cancer Screening Software Market Size and Forecast by Region
1.8.1 Global Lung Cancer Screening Software Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Lung Cancer Screening Software Market Size by Region, (2021-2032)
1.8.3 North America Lung Cancer Screening Software Market Size and Prospect (2021-2032)
1.8.4 Europe Lung Cancer Screening Software Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Lung Cancer Screening Software Market Size and Prospect (2021-2032)
1.8.6 South America Lung Cancer Screening Software Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Lung Cancer Screening Software Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Siemens Healthineers
2.1.1 Siemens Healthineers Details
2.1.2 Siemens Healthineers Major Business
2.1.3 Siemens Healthineers Lung Cancer Screening Software Product and Solutions
2.1.4 Siemens Healthineers Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Siemens Healthineers Recent Developments and Future Plans
2.2 GE HealthCare
2.2.1 GE HealthCare Details
2.2.2 GE HealthCare Major Business
2.2.3 GE HealthCare Lung Cancer Screening Software Product and Solutions
2.2.4 GE HealthCare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 GE HealthCare Recent Developments and Future Plans
2.3 Philips Healthcare
2.3.1 Philips Healthcare Details
2.3.2 Philips Healthcare Major Business
2.3.3 Philips Healthcare Lung Cancer Screening Software Product and Solutions
2.3.4 Philips Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Philips Healthcare Recent Developments and Future Plans
2.4 Canon Medical Systems
2.4.1 Canon Medical Systems Details
2.4.2 Canon Medical Systems Major Business
2.4.3 Canon Medical Systems Lung Cancer Screening Software Product and Solutions
2.4.4 Canon Medical Systems Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Canon Medical Systems Recent Developments and Future Plans
2.5 United Imaging Healthcare
2.5.1 United Imaging Healthcare Details
2.5.2 United Imaging Healthcare Major Business
2.5.3 United Imaging Healthcare Lung Cancer Screening Software Product and Solutions
2.5.4 United Imaging Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 United Imaging Healthcare Recent Developments and Future Plans
2.6 InferVision
2.6.1 InferVision Details
2.6.2 InferVision Major Business
2.6.3 InferVision Lung Cancer Screening Software Product and Solutions
2.6.4 InferVision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 InferVision Recent Developments and Future Plans
2.7 Airdoc
2.7.1 Airdoc Details
2.7.2 Airdoc Major Business
2.7.3 Airdoc Lung Cancer Screening Software Product and Solutions
2.7.4 Airdoc Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Airdoc Recent Developments and Future Plans
2.8 VUNO
2.8.1 VUNO Details
2.8.2 VUNO Major Business
2.8.3 VUNO Lung Cancer Screening Software Product and Solutions
2.8.4 VUNO Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 VUNO Recent Developments and Future Plans
2.9 Lunit
2.9.1 Lunit Details
2.9.2 Lunit Major Business
2.9.3 Lunit Lung Cancer Screening Software Product and Solutions
2.9.4 Lunit Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Lunit Recent Developments and Future Plans
2.10 Qure.ai
2.10.1 Qure.ai Details
2.10.2 Qure.ai Major Business
2.10.3 Qure.ai Lung Cancer Screening Software Product and Solutions
2.10.4 Qure.ai Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Qure.ai Recent Developments and Future Plans
2.11 Riverain Technologies
2.11.1 Riverain Technologies Details
2.11.2 Riverain Technologies Major Business
2.11.3 Riverain Technologies Lung Cancer Screening Software Product and Solutions
2.11.4 Riverain Technologies Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Riverain Technologies Recent Developments and Future Plans
2.12 Zebra Medical Vision
2.12.1 Zebra Medical Vision Details
2.12.2 Zebra Medical Vision Major Business
2.12.3 Zebra Medical Vision Lung Cancer Screening Software Product and Solutions
2.12.4 Zebra Medical Vision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Zebra Medical Vision Recent Developments and Future Plans
2.13 Arterys
2.13.1 Arterys Details
2.13.2 Arterys Major Business
2.13.3 Arterys Lung Cancer Screening Software Product and Solutions
2.13.4 Arterys Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Arterys Recent Developments and Future Plans
2.14 Deepwise
2.14.1 Deepwise Details
2.14.2 Deepwise Major Business
2.14.3 Deepwise Lung Cancer Screening Software Product and Solutions
2.14.4 Deepwise Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Deepwise Recent Developments and Future Plans
2.15 EverFortune AI
2.15.1 EverFortune AI Details
2.15.2 EverFortune AI Major Business
2.15.3 EverFortune AI Lung Cancer Screening Software Product and Solutions
2.15.4 EverFortune AI Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 EverFortune AI Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lung Cancer Screening Software Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Lung Cancer Screening Software by Company Revenue
3.2.2 Top 3 Lung Cancer Screening Software Players Market Share in 2025
3.2.3 Top 6 Lung Cancer Screening Software Players Market Share in 2025
3.3 Lung Cancer Screening Software Market: Overall Company Footprint Analysis
3.3.1 Lung Cancer Screening Software Market: Region Footprint
3.3.2 Lung Cancer Screening Software Market: Company Product Type Footprint
3.3.3 Lung Cancer Screening Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lung Cancer Screening Software Consumption Value and Market Share by Type (2021-2026)
4.2 Global Lung Cancer Screening Software Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2026)
5.2 Global Lung Cancer Screening Software Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Lung Cancer Screening Software Consumption Value by Type (2021-2032)
6.2 North America Lung Cancer Screening Software Market Size by Application (2021-2032)
6.3 North America Lung Cancer Screening Software Market Size by Country
6.3.1 North America Lung Cancer Screening Software Consumption Value by Country (2021-2032)
6.3.2 United States Lung Cancer Screening Software Market Size and Forecast (2021-2032)
6.3.3 Canada Lung Cancer Screening Software Market Size and Forecast (2021-2032)
6.3.4 Mexico Lung Cancer Screening Software Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Lung Cancer Screening Software Consumption Value by Type (2021-2032)
7.2 Europe Lung Cancer Screening Software Consumption Value by Application (2021-2032)
7.3 Europe Lung Cancer Screening Software Market Size by Country
7.3.1 Europe Lung Cancer Screening Software Consumption Value by Country (2021-2032)
7.3.2 Germany Lung Cancer Screening Software Market Size and Forecast (2021-2032)
7.3.3 France Lung Cancer Screening Software Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Lung Cancer Screening Software Market Size and Forecast (2021-2032)
7.3.5 Russia Lung Cancer Screening Software Market Size and Forecast (2021-2032)
7.3.6 Italy Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lung Cancer Screening Software Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Lung Cancer Screening Software Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Lung Cancer Screening Software Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Screening Software Consumption Value by Region (2021-2032)
8.3.2 China Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8.3.3 Japan Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8.3.4 South Korea Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8.3.5 India Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8.3.7 Australia Lung Cancer Screening Software Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Lung Cancer Screening Software Consumption Value by Type (2021-2032)
9.2 South America Lung Cancer Screening Software Consumption Value by Application (2021-2032)
9.3 South America Lung Cancer Screening Software Market Size by Country
9.3.1 South America Lung Cancer Screening Software Consumption Value by Country (2021-2032)
9.3.2 Brazil Lung Cancer Screening Software Market Size and Forecast (2021-2032)
9.3.3 Argentina Lung Cancer Screening Software Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lung Cancer Screening Software Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Lung Cancer Screening Software Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Lung Cancer Screening Software Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Screening Software Consumption Value by Country (2021-2032)
10.3.2 Turkey Lung Cancer Screening Software Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Lung Cancer Screening Software Market Size and Forecast (2021-2032)
10.3.4 UAE Lung Cancer Screening Software Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Lung Cancer Screening Software Market Drivers
11.2 Lung Cancer Screening Software Market Restraints
11.3 Lung Cancer Screening Software Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Lung Cancer Screening Software Industry Chain
12.2 Lung Cancer Screening Software Upstream Analysis
12.3 Lung Cancer Screening Software Midstream Analysis
12.4 Lung Cancer Screening Software Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lung Cancer Screening Software by Type
1.3.1 Overview: Global Lung Cancer Screening Software Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Lung Cancer Screening Software Consumption Value Market Share by Type in 2025
1.3.3 Cloud-Based
1.3.4 Web-Based
1.4 Classification of Lung Cancer Screening Software by Screening Technologies
1.4.1 Overview: Global Lung Cancer Screening Software Market Size by Screening Technologies: 2021 Versus 2025 Versus 2032
1.4.2 Global Lung Cancer Screening Software Consumption Value Market Share by Screening Technologies in 2025
1.4.3 Nodule Detection
1.4.4 Nodule Analysis
1.4.5 Full-Process Screening
1.4.6 Predictive Assessment
1.5 Classification of Lung Cancer Screening Software by System Integration Level
1.5.1 Overview: Global Lung Cancer Screening Software Market Size by System Integration Level: 2021 Versus 2025 Versus 2032
1.5.2 Global Lung Cancer Screening Software Consumption Value Market Share by System Integration Level in 2025
1.5.3 Standalone AI Software
1.5.4 PACS/RIS Integrated Plugin
1.5.5 Built-in Solution for Imaging Equipment
1.5.6 Regional Screening Platform System
1.6 Global Lung Cancer Screening Software Market by Application
1.6.1 Overview: Global Lung Cancer Screening Software Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals
1.6.3 Medical Examination Institutions
1.6.4 Public Health Screening
1.6.5 Others
1.7 Global Lung Cancer Screening Software Market Size & Forecast
1.8 Global Lung Cancer Screening Software Market Size and Forecast by Region
1.8.1 Global Lung Cancer Screening Software Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Lung Cancer Screening Software Market Size by Region, (2021-2032)
1.8.3 North America Lung Cancer Screening Software Market Size and Prospect (2021-2032)
1.8.4 Europe Lung Cancer Screening Software Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Lung Cancer Screening Software Market Size and Prospect (2021-2032)
1.8.6 South America Lung Cancer Screening Software Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Lung Cancer Screening Software Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Siemens Healthineers
2.1.1 Siemens Healthineers Details
2.1.2 Siemens Healthineers Major Business
2.1.3 Siemens Healthineers Lung Cancer Screening Software Product and Solutions
2.1.4 Siemens Healthineers Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Siemens Healthineers Recent Developments and Future Plans
2.2 GE HealthCare
2.2.1 GE HealthCare Details
2.2.2 GE HealthCare Major Business
2.2.3 GE HealthCare Lung Cancer Screening Software Product and Solutions
2.2.4 GE HealthCare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 GE HealthCare Recent Developments and Future Plans
2.3 Philips Healthcare
2.3.1 Philips Healthcare Details
2.3.2 Philips Healthcare Major Business
2.3.3 Philips Healthcare Lung Cancer Screening Software Product and Solutions
2.3.4 Philips Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Philips Healthcare Recent Developments and Future Plans
2.4 Canon Medical Systems
2.4.1 Canon Medical Systems Details
2.4.2 Canon Medical Systems Major Business
2.4.3 Canon Medical Systems Lung Cancer Screening Software Product and Solutions
2.4.4 Canon Medical Systems Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Canon Medical Systems Recent Developments and Future Plans
2.5 United Imaging Healthcare
2.5.1 United Imaging Healthcare Details
2.5.2 United Imaging Healthcare Major Business
2.5.3 United Imaging Healthcare Lung Cancer Screening Software Product and Solutions
2.5.4 United Imaging Healthcare Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 United Imaging Healthcare Recent Developments and Future Plans
2.6 InferVision
2.6.1 InferVision Details
2.6.2 InferVision Major Business
2.6.3 InferVision Lung Cancer Screening Software Product and Solutions
2.6.4 InferVision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 InferVision Recent Developments and Future Plans
2.7 Airdoc
2.7.1 Airdoc Details
2.7.2 Airdoc Major Business
2.7.3 Airdoc Lung Cancer Screening Software Product and Solutions
2.7.4 Airdoc Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Airdoc Recent Developments and Future Plans
2.8 VUNO
2.8.1 VUNO Details
2.8.2 VUNO Major Business
2.8.3 VUNO Lung Cancer Screening Software Product and Solutions
2.8.4 VUNO Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 VUNO Recent Developments and Future Plans
2.9 Lunit
2.9.1 Lunit Details
2.9.2 Lunit Major Business
2.9.3 Lunit Lung Cancer Screening Software Product and Solutions
2.9.4 Lunit Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Lunit Recent Developments and Future Plans
2.10 Qure.ai
2.10.1 Qure.ai Details
2.10.2 Qure.ai Major Business
2.10.3 Qure.ai Lung Cancer Screening Software Product and Solutions
2.10.4 Qure.ai Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Qure.ai Recent Developments and Future Plans
2.11 Riverain Technologies
2.11.1 Riverain Technologies Details
2.11.2 Riverain Technologies Major Business
2.11.3 Riverain Technologies Lung Cancer Screening Software Product and Solutions
2.11.4 Riverain Technologies Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Riverain Technologies Recent Developments and Future Plans
2.12 Zebra Medical Vision
2.12.1 Zebra Medical Vision Details
2.12.2 Zebra Medical Vision Major Business
2.12.3 Zebra Medical Vision Lung Cancer Screening Software Product and Solutions
2.12.4 Zebra Medical Vision Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Zebra Medical Vision Recent Developments and Future Plans
2.13 Arterys
2.13.1 Arterys Details
2.13.2 Arterys Major Business
2.13.3 Arterys Lung Cancer Screening Software Product and Solutions
2.13.4 Arterys Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Arterys Recent Developments and Future Plans
2.14 Deepwise
2.14.1 Deepwise Details
2.14.2 Deepwise Major Business
2.14.3 Deepwise Lung Cancer Screening Software Product and Solutions
2.14.4 Deepwise Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Deepwise Recent Developments and Future Plans
2.15 EverFortune AI
2.15.1 EverFortune AI Details
2.15.2 EverFortune AI Major Business
2.15.3 EverFortune AI Lung Cancer Screening Software Product and Solutions
2.15.4 EverFortune AI Lung Cancer Screening Software Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 EverFortune AI Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lung Cancer Screening Software Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Lung Cancer Screening Software by Company Revenue
3.2.2 Top 3 Lung Cancer Screening Software Players Market Share in 2025
3.2.3 Top 6 Lung Cancer Screening Software Players Market Share in 2025
3.3 Lung Cancer Screening Software Market: Overall Company Footprint Analysis
3.3.1 Lung Cancer Screening Software Market: Region Footprint
3.3.2 Lung Cancer Screening Software Market: Company Product Type Footprint
3.3.3 Lung Cancer Screening Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lung Cancer Screening Software Consumption Value and Market Share by Type (2021-2026)
4.2 Global Lung Cancer Screening Software Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2026)
5.2 Global Lung Cancer Screening Software Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Lung Cancer Screening Software Consumption Value by Type (2021-2032)
6.2 North America Lung Cancer Screening Software Market Size by Application (2021-2032)
6.3 North America Lung Cancer Screening Software Market Size by Country
6.3.1 North America Lung Cancer Screening Software Consumption Value by Country (2021-2032)
6.3.2 United States Lung Cancer Screening Software Market Size and Forecast (2021-2032)
6.3.3 Canada Lung Cancer Screening Software Market Size and Forecast (2021-2032)
6.3.4 Mexico Lung Cancer Screening Software Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Lung Cancer Screening Software Consumption Value by Type (2021-2032)
7.2 Europe Lung Cancer Screening Software Consumption Value by Application (2021-2032)
7.3 Europe Lung Cancer Screening Software Market Size by Country
7.3.1 Europe Lung Cancer Screening Software Consumption Value by Country (2021-2032)
7.3.2 Germany Lung Cancer Screening Software Market Size and Forecast (2021-2032)
7.3.3 France Lung Cancer Screening Software Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Lung Cancer Screening Software Market Size and Forecast (2021-2032)
7.3.5 Russia Lung Cancer Screening Software Market Size and Forecast (2021-2032)
7.3.6 Italy Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lung Cancer Screening Software Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Lung Cancer Screening Software Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Lung Cancer Screening Software Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Screening Software Consumption Value by Region (2021-2032)
8.3.2 China Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8.3.3 Japan Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8.3.4 South Korea Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8.3.5 India Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Lung Cancer Screening Software Market Size and Forecast (2021-2032)
8.3.7 Australia Lung Cancer Screening Software Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Lung Cancer Screening Software Consumption Value by Type (2021-2032)
9.2 South America Lung Cancer Screening Software Consumption Value by Application (2021-2032)
9.3 South America Lung Cancer Screening Software Market Size by Country
9.3.1 South America Lung Cancer Screening Software Consumption Value by Country (2021-2032)
9.3.2 Brazil Lung Cancer Screening Software Market Size and Forecast (2021-2032)
9.3.3 Argentina Lung Cancer Screening Software Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lung Cancer Screening Software Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Lung Cancer Screening Software Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Lung Cancer Screening Software Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Screening Software Consumption Value by Country (2021-2032)
10.3.2 Turkey Lung Cancer Screening Software Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Lung Cancer Screening Software Market Size and Forecast (2021-2032)
10.3.4 UAE Lung Cancer Screening Software Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Lung Cancer Screening Software Market Drivers
11.2 Lung Cancer Screening Software Market Restraints
11.3 Lung Cancer Screening Software Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Lung Cancer Screening Software Industry Chain
12.2 Lung Cancer Screening Software Upstream Analysis
12.3 Lung Cancer Screening Software Midstream Analysis
12.4 Lung Cancer Screening Software Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Lung Cancer Screening Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Lung Cancer Screening Software Consumption Value by Screening Technologies, (USD Million), 2021 & 2025 & 2032
Table 3. Global Lung Cancer Screening Software Consumption Value by System Integration Level, (USD Million), 2021 & 2025 & 2032
Table 4. Global Lung Cancer Screening Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Lung Cancer Screening Software Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Lung Cancer Screening Software Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 8. Siemens Healthineers Major Business
Table 9. Siemens Healthineers Lung Cancer Screening Software Product and Solutions
Table 10. Siemens Healthineers Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Siemens Healthineers Recent Developments and Future Plans
Table 12. GE HealthCare Company Information, Head Office, and Major Competitors
Table 13. GE HealthCare Major Business
Table 14. GE HealthCare Lung Cancer Screening Software Product and Solutions
Table 15. GE HealthCare Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. GE HealthCare Recent Developments and Future Plans
Table 17. Philips Healthcare Company Information, Head Office, and Major Competitors
Table 18. Philips Healthcare Major Business
Table 19. Philips Healthcare Lung Cancer Screening Software Product and Solutions
Table 20. Philips Healthcare Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Canon Medical Systems Company Information, Head Office, and Major Competitors
Table 22. Canon Medical Systems Major Business
Table 23. Canon Medical Systems Lung Cancer Screening Software Product and Solutions
Table 24. Canon Medical Systems Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Canon Medical Systems Recent Developments and Future Plans
Table 26. United Imaging Healthcare Company Information, Head Office, and Major Competitors
Table 27. United Imaging Healthcare Major Business
Table 28. United Imaging Healthcare Lung Cancer Screening Software Product and Solutions
Table 29. United Imaging Healthcare Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. United Imaging Healthcare Recent Developments and Future Plans
Table 31. InferVision Company Information, Head Office, and Major Competitors
Table 32. InferVision Major Business
Table 33. InferVision Lung Cancer Screening Software Product and Solutions
Table 34. InferVision Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. InferVision Recent Developments and Future Plans
Table 36. Airdoc Company Information, Head Office, and Major Competitors
Table 37. Airdoc Major Business
Table 38. Airdoc Lung Cancer Screening Software Product and Solutions
Table 39. Airdoc Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Airdoc Recent Developments and Future Plans
Table 41. VUNO Company Information, Head Office, and Major Competitors
Table 42. VUNO Major Business
Table 43. VUNO Lung Cancer Screening Software Product and Solutions
Table 44. VUNO Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. VUNO Recent Developments and Future Plans
Table 46. Lunit Company Information, Head Office, and Major Competitors
Table 47. Lunit Major Business
Table 48. Lunit Lung Cancer Screening Software Product and Solutions
Table 49. Lunit Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Lunit Recent Developments and Future Plans
Table 51. Qure.ai Company Information, Head Office, and Major Competitors
Table 52. Qure.ai Major Business
Table 53. Qure.ai Lung Cancer Screening Software Product and Solutions
Table 54. Qure.ai Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Qure.ai Recent Developments and Future Plans
Table 56. Riverain Technologies Company Information, Head Office, and Major Competitors
Table 57. Riverain Technologies Major Business
Table 58. Riverain Technologies Lung Cancer Screening Software Product and Solutions
Table 59. Riverain Technologies Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Riverain Technologies Recent Developments and Future Plans
Table 61. Zebra Medical Vision Company Information, Head Office, and Major Competitors
Table 62. Zebra Medical Vision Major Business
Table 63. Zebra Medical Vision Lung Cancer Screening Software Product and Solutions
Table 64. Zebra Medical Vision Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Zebra Medical Vision Recent Developments and Future Plans
Table 66. Arterys Company Information, Head Office, and Major Competitors
Table 67. Arterys Major Business
Table 68. Arterys Lung Cancer Screening Software Product and Solutions
Table 69. Arterys Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Arterys Recent Developments and Future Plans
Table 71. Deepwise Company Information, Head Office, and Major Competitors
Table 72. Deepwise Major Business
Table 73. Deepwise Lung Cancer Screening Software Product and Solutions
Table 74. Deepwise Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Deepwise Recent Developments and Future Plans
Table 76. EverFortune AI Company Information, Head Office, and Major Competitors
Table 77. EverFortune AI Major Business
Table 78. EverFortune AI Lung Cancer Screening Software Product and Solutions
Table 79. EverFortune AI Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. EverFortune AI Recent Developments and Future Plans
Table 81. Global Lung Cancer Screening Software Revenue (USD Million) by Players (2021-2026)
Table 82. Global Lung Cancer Screening Software Revenue Share by Players (2021-2026)
Table 83. Breakdown of Lung Cancer Screening Software by Company Type (Tier 1, Tier 2, and Tier 3)
Table 84. Market Position of Players in Lung Cancer Screening Software, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 85. Head Office of Key Lung Cancer Screening Software Players
Table 86. Lung Cancer Screening Software Market: Company Product Type Footprint
Table 87. Lung Cancer Screening Software Market: Company Product Application Footprint
Table 88. Lung Cancer Screening Software New Market Entrants and Barriers to Market Entry
Table 89. Lung Cancer Screening Software Mergers, Acquisition, Agreements, and Collaborations
Table 90. Global Lung Cancer Screening Software Consumption Value (USD Million) by Type (2021-2026)
Table 91. Global Lung Cancer Screening Software Consumption Value Share by Type (2021-2026)
Table 92. Global Lung Cancer Screening Software Consumption Value Forecast by Type (2027-2032)
Table 93. Global Lung Cancer Screening Software Consumption Value by Application (2021-2026)
Table 94. Global Lung Cancer Screening Software Consumption Value Forecast by Application (2027-2032)
Table 95. North America Lung Cancer Screening Software Consumption Value by Type (2021-2026) & (USD Million)
Table 96. North America Lung Cancer Screening Software Consumption Value by Type (2027-2032) & (USD Million)
Table 97. North America Lung Cancer Screening Software Consumption Value by Application (2021-2026) & (USD Million)
Table 98. North America Lung Cancer Screening Software Consumption Value by Application (2027-2032) & (USD Million)
Table 99. North America Lung Cancer Screening Software Consumption Value by Country (2021-2026) & (USD Million)
Table 100. North America Lung Cancer Screening Software Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Europe Lung Cancer Screening Software Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Europe Lung Cancer Screening Software Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Europe Lung Cancer Screening Software Consumption Value by Application (2021-2026) & (USD Million)
Table 104. Europe Lung Cancer Screening Software Consumption Value by Application (2027-2032) & (USD Million)
Table 105. Europe Lung Cancer Screening Software Consumption Value by Country (2021-2026) & (USD Million)
Table 106. Europe Lung Cancer Screening Software Consumption Value by Country (2027-2032) & (USD Million)
Table 107. Asia-Pacific Lung Cancer Screening Software Consumption Value by Type (2021-2026) & (USD Million)
Table 108. Asia-Pacific Lung Cancer Screening Software Consumption Value by Type (2027-2032) & (USD Million)
Table 109. Asia-Pacific Lung Cancer Screening Software Consumption Value by Application (2021-2026) & (USD Million)
Table 110. Asia-Pacific Lung Cancer Screening Software Consumption Value by Application (2027-2032) & (USD Million)
Table 111. Asia-Pacific Lung Cancer Screening Software Consumption Value by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Lung Cancer Screening Software Consumption Value by Region (2027-2032) & (USD Million)
Table 113. South America Lung Cancer Screening Software Consumption Value by Type (2021-2026) & (USD Million)
Table 114. South America Lung Cancer Screening Software Consumption Value by Type (2027-2032) & (USD Million)
Table 115. South America Lung Cancer Screening Software Consumption Value by Application (2021-2026) & (USD Million)
Table 116. South America Lung Cancer Screening Software Consumption Value by Application (2027-2032) & (USD Million)
Table 117. South America Lung Cancer Screening Software Consumption Value by Country (2021-2026) & (USD Million)
Table 118. South America Lung Cancer Screening Software Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Middle East & Africa Lung Cancer Screening Software Consumption Value by Type (2021-2026) & (USD Million)
Table 120. Middle East & Africa Lung Cancer Screening Software Consumption Value by Type (2027-2032) & (USD Million)
Table 121. Middle East & Africa Lung Cancer Screening Software Consumption Value by Application (2021-2026) & (USD Million)
Table 122. Middle East & Africa Lung Cancer Screening Software Consumption Value by Application (2027-2032) & (USD Million)
Table 123. Middle East & Africa Lung Cancer Screening Software Consumption Value by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Lung Cancer Screening Software Consumption Value by Country (2027-2032) & (USD Million)
Table 125. Global Key Players of Lung Cancer Screening Software Upstream (Raw Materials)
Table 126. Global Lung Cancer Screening Software Typical Customers
Table 1. Global Lung Cancer Screening Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Lung Cancer Screening Software Consumption Value by Screening Technologies, (USD Million), 2021 & 2025 & 2032
Table 3. Global Lung Cancer Screening Software Consumption Value by System Integration Level, (USD Million), 2021 & 2025 & 2032
Table 4. Global Lung Cancer Screening Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Lung Cancer Screening Software Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Lung Cancer Screening Software Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 8. Siemens Healthineers Major Business
Table 9. Siemens Healthineers Lung Cancer Screening Software Product and Solutions
Table 10. Siemens Healthineers Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Siemens Healthineers Recent Developments and Future Plans
Table 12. GE HealthCare Company Information, Head Office, and Major Competitors
Table 13. GE HealthCare Major Business
Table 14. GE HealthCare Lung Cancer Screening Software Product and Solutions
Table 15. GE HealthCare Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. GE HealthCare Recent Developments and Future Plans
Table 17. Philips Healthcare Company Information, Head Office, and Major Competitors
Table 18. Philips Healthcare Major Business
Table 19. Philips Healthcare Lung Cancer Screening Software Product and Solutions
Table 20. Philips Healthcare Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Canon Medical Systems Company Information, Head Office, and Major Competitors
Table 22. Canon Medical Systems Major Business
Table 23. Canon Medical Systems Lung Cancer Screening Software Product and Solutions
Table 24. Canon Medical Systems Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Canon Medical Systems Recent Developments and Future Plans
Table 26. United Imaging Healthcare Company Information, Head Office, and Major Competitors
Table 27. United Imaging Healthcare Major Business
Table 28. United Imaging Healthcare Lung Cancer Screening Software Product and Solutions
Table 29. United Imaging Healthcare Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. United Imaging Healthcare Recent Developments and Future Plans
Table 31. InferVision Company Information, Head Office, and Major Competitors
Table 32. InferVision Major Business
Table 33. InferVision Lung Cancer Screening Software Product and Solutions
Table 34. InferVision Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. InferVision Recent Developments and Future Plans
Table 36. Airdoc Company Information, Head Office, and Major Competitors
Table 37. Airdoc Major Business
Table 38. Airdoc Lung Cancer Screening Software Product and Solutions
Table 39. Airdoc Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Airdoc Recent Developments and Future Plans
Table 41. VUNO Company Information, Head Office, and Major Competitors
Table 42. VUNO Major Business
Table 43. VUNO Lung Cancer Screening Software Product and Solutions
Table 44. VUNO Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. VUNO Recent Developments and Future Plans
Table 46. Lunit Company Information, Head Office, and Major Competitors
Table 47. Lunit Major Business
Table 48. Lunit Lung Cancer Screening Software Product and Solutions
Table 49. Lunit Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Lunit Recent Developments and Future Plans
Table 51. Qure.ai Company Information, Head Office, and Major Competitors
Table 52. Qure.ai Major Business
Table 53. Qure.ai Lung Cancer Screening Software Product and Solutions
Table 54. Qure.ai Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Qure.ai Recent Developments and Future Plans
Table 56. Riverain Technologies Company Information, Head Office, and Major Competitors
Table 57. Riverain Technologies Major Business
Table 58. Riverain Technologies Lung Cancer Screening Software Product and Solutions
Table 59. Riverain Technologies Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Riverain Technologies Recent Developments and Future Plans
Table 61. Zebra Medical Vision Company Information, Head Office, and Major Competitors
Table 62. Zebra Medical Vision Major Business
Table 63. Zebra Medical Vision Lung Cancer Screening Software Product and Solutions
Table 64. Zebra Medical Vision Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Zebra Medical Vision Recent Developments and Future Plans
Table 66. Arterys Company Information, Head Office, and Major Competitors
Table 67. Arterys Major Business
Table 68. Arterys Lung Cancer Screening Software Product and Solutions
Table 69. Arterys Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Arterys Recent Developments and Future Plans
Table 71. Deepwise Company Information, Head Office, and Major Competitors
Table 72. Deepwise Major Business
Table 73. Deepwise Lung Cancer Screening Software Product and Solutions
Table 74. Deepwise Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Deepwise Recent Developments and Future Plans
Table 76. EverFortune AI Company Information, Head Office, and Major Competitors
Table 77. EverFortune AI Major Business
Table 78. EverFortune AI Lung Cancer Screening Software Product and Solutions
Table 79. EverFortune AI Lung Cancer Screening Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. EverFortune AI Recent Developments and Future Plans
Table 81. Global Lung Cancer Screening Software Revenue (USD Million) by Players (2021-2026)
Table 82. Global Lung Cancer Screening Software Revenue Share by Players (2021-2026)
Table 83. Breakdown of Lung Cancer Screening Software by Company Type (Tier 1, Tier 2, and Tier 3)
Table 84. Market Position of Players in Lung Cancer Screening Software, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 85. Head Office of Key Lung Cancer Screening Software Players
Table 86. Lung Cancer Screening Software Market: Company Product Type Footprint
Table 87. Lung Cancer Screening Software Market: Company Product Application Footprint
Table 88. Lung Cancer Screening Software New Market Entrants and Barriers to Market Entry
Table 89. Lung Cancer Screening Software Mergers, Acquisition, Agreements, and Collaborations
Table 90. Global Lung Cancer Screening Software Consumption Value (USD Million) by Type (2021-2026)
Table 91. Global Lung Cancer Screening Software Consumption Value Share by Type (2021-2026)
Table 92. Global Lung Cancer Screening Software Consumption Value Forecast by Type (2027-2032)
Table 93. Global Lung Cancer Screening Software Consumption Value by Application (2021-2026)
Table 94. Global Lung Cancer Screening Software Consumption Value Forecast by Application (2027-2032)
Table 95. North America Lung Cancer Screening Software Consumption Value by Type (2021-2026) & (USD Million)
Table 96. North America Lung Cancer Screening Software Consumption Value by Type (2027-2032) & (USD Million)
Table 97. North America Lung Cancer Screening Software Consumption Value by Application (2021-2026) & (USD Million)
Table 98. North America Lung Cancer Screening Software Consumption Value by Application (2027-2032) & (USD Million)
Table 99. North America Lung Cancer Screening Software Consumption Value by Country (2021-2026) & (USD Million)
Table 100. North America Lung Cancer Screening Software Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Europe Lung Cancer Screening Software Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Europe Lung Cancer Screening Software Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Europe Lung Cancer Screening Software Consumption Value by Application (2021-2026) & (USD Million)
Table 104. Europe Lung Cancer Screening Software Consumption Value by Application (2027-2032) & (USD Million)
Table 105. Europe Lung Cancer Screening Software Consumption Value by Country (2021-2026) & (USD Million)
Table 106. Europe Lung Cancer Screening Software Consumption Value by Country (2027-2032) & (USD Million)
Table 107. Asia-Pacific Lung Cancer Screening Software Consumption Value by Type (2021-2026) & (USD Million)
Table 108. Asia-Pacific Lung Cancer Screening Software Consumption Value by Type (2027-2032) & (USD Million)
Table 109. Asia-Pacific Lung Cancer Screening Software Consumption Value by Application (2021-2026) & (USD Million)
Table 110. Asia-Pacific Lung Cancer Screening Software Consumption Value by Application (2027-2032) & (USD Million)
Table 111. Asia-Pacific Lung Cancer Screening Software Consumption Value by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Lung Cancer Screening Software Consumption Value by Region (2027-2032) & (USD Million)
Table 113. South America Lung Cancer Screening Software Consumption Value by Type (2021-2026) & (USD Million)
Table 114. South America Lung Cancer Screening Software Consumption Value by Type (2027-2032) & (USD Million)
Table 115. South America Lung Cancer Screening Software Consumption Value by Application (2021-2026) & (USD Million)
Table 116. South America Lung Cancer Screening Software Consumption Value by Application (2027-2032) & (USD Million)
Table 117. South America Lung Cancer Screening Software Consumption Value by Country (2021-2026) & (USD Million)
Table 118. South America Lung Cancer Screening Software Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Middle East & Africa Lung Cancer Screening Software Consumption Value by Type (2021-2026) & (USD Million)
Table 120. Middle East & Africa Lung Cancer Screening Software Consumption Value by Type (2027-2032) & (USD Million)
Table 121. Middle East & Africa Lung Cancer Screening Software Consumption Value by Application (2021-2026) & (USD Million)
Table 122. Middle East & Africa Lung Cancer Screening Software Consumption Value by Application (2027-2032) & (USD Million)
Table 123. Middle East & Africa Lung Cancer Screening Software Consumption Value by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Lung Cancer Screening Software Consumption Value by Country (2027-2032) & (USD Million)
Table 125. Global Key Players of Lung Cancer Screening Software Upstream (Raw Materials)
Table 126. Global Lung Cancer Screening Software Typical Customers
LIST OF FIGURES
Figure 1. Lung Cancer Screening Software Picture
Figure 2. Global Lung Cancer Screening Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Lung Cancer Screening Software Consumption Value Market Share by Type in 2025
Figure 4. Cloud-Based
Figure 5. Web-Based
Figure 6. Global Lung Cancer Screening Software Consumption Value by Screening Technologies, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Lung Cancer Screening Software Consumption Value Market Share by Screening Technologies in 2025
Figure 8. Nodule Detection
Figure 9. Nodule Analysis
Figure 10. Full-Process Screening
Figure 11. Predictive Assessment
Figure 12. Global Lung Cancer Screening Software Consumption Value by System Integration Level, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Lung Cancer Screening Software Consumption Value Market Share by System Integration Level in 2025
Figure 14. Standalone AI Software
Figure 15. PACS/RIS Integrated Plugin
Figure 16. Built-in Solution for Imaging Equipment
Figure 17. Regional Screening Platform System
Figure 18. Global Lung Cancer Screening Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Lung Cancer Screening Software Consumption Value Market Share by Application in 2025
Figure 20. Hospitals Picture
Figure 21. Medical Examination Institutions Picture
Figure 22. Public Health Screening Picture
Figure 23. Others Picture
Figure 24. Global Lung Cancer Screening Software Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Lung Cancer Screening Software Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Market Lung Cancer Screening Software Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 27. Global Lung Cancer Screening Software Consumption Value Market Share by Region (2021-2032)
Figure 28. Global Lung Cancer Screening Software Consumption Value Market Share by Region in 2025
Figure 29. North America Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 34. Company Three Recent Developments and Future Plans
Figure 35. Global Lung Cancer Screening Software Revenue Share by Players in 2025
Figure 36. Lung Cancer Screening Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 37. Market Share of Lung Cancer Screening Software by Player Revenue in 2025
Figure 38. Top 3 Lung Cancer Screening Software Players Market Share in 2025
Figure 39. Top 6 Lung Cancer Screening Software Players Market Share in 2025
Figure 40. Global Lung Cancer Screening Software Consumption Value Share by Type (2021-2026)
Figure 41. Global Lung Cancer Screening Software Market Share Forecast by Type (2027-2032)
Figure 42. Global Lung Cancer Screening Software Consumption Value Share by Application (2021-2026)
Figure 43. Global Lung Cancer Screening Software Market Share Forecast by Application (2027-2032)
Figure 44. North America Lung Cancer Screening Software Consumption Value Market Share by Type (2021-2032)
Figure 45. North America Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2032)
Figure 46. North America Lung Cancer Screening Software Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Lung Cancer Screening Software Consumption Value Market Share by Type (2021-2032)
Figure 51. Europe Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2032)
Figure 52. Europe Lung Cancer Screening Software Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 54. France Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Lung Cancer Screening Software Consumption Value Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Lung Cancer Screening Software Consumption Value Market Share by Region (2021-2032)
Figure 61. China Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 64. India Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Lung Cancer Screening Software Consumption Value Market Share by Type (2021-2032)
Figure 68. South America Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2032)
Figure 69. South America Lung Cancer Screening Software Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Lung Cancer Screening Software Consumption Value Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Lung Cancer Screening Software Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 77. UAE Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 78. Lung Cancer Screening Software Market Drivers
Figure 79. Lung Cancer Screening Software Market Restraints
Figure 80. Lung Cancer Screening Software Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Lung Cancer Screening Software Industrial Chain
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Lung Cancer Screening Software Picture
Figure 2. Global Lung Cancer Screening Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Lung Cancer Screening Software Consumption Value Market Share by Type in 2025
Figure 4. Cloud-Based
Figure 5. Web-Based
Figure 6. Global Lung Cancer Screening Software Consumption Value by Screening Technologies, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Lung Cancer Screening Software Consumption Value Market Share by Screening Technologies in 2025
Figure 8. Nodule Detection
Figure 9. Nodule Analysis
Figure 10. Full-Process Screening
Figure 11. Predictive Assessment
Figure 12. Global Lung Cancer Screening Software Consumption Value by System Integration Level, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Lung Cancer Screening Software Consumption Value Market Share by System Integration Level in 2025
Figure 14. Standalone AI Software
Figure 15. PACS/RIS Integrated Plugin
Figure 16. Built-in Solution for Imaging Equipment
Figure 17. Regional Screening Platform System
Figure 18. Global Lung Cancer Screening Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Lung Cancer Screening Software Consumption Value Market Share by Application in 2025
Figure 20. Hospitals Picture
Figure 21. Medical Examination Institutions Picture
Figure 22. Public Health Screening Picture
Figure 23. Others Picture
Figure 24. Global Lung Cancer Screening Software Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Lung Cancer Screening Software Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Market Lung Cancer Screening Software Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 27. Global Lung Cancer Screening Software Consumption Value Market Share by Region (2021-2032)
Figure 28. Global Lung Cancer Screening Software Consumption Value Market Share by Region in 2025
Figure 29. North America Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 34. Company Three Recent Developments and Future Plans
Figure 35. Global Lung Cancer Screening Software Revenue Share by Players in 2025
Figure 36. Lung Cancer Screening Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 37. Market Share of Lung Cancer Screening Software by Player Revenue in 2025
Figure 38. Top 3 Lung Cancer Screening Software Players Market Share in 2025
Figure 39. Top 6 Lung Cancer Screening Software Players Market Share in 2025
Figure 40. Global Lung Cancer Screening Software Consumption Value Share by Type (2021-2026)
Figure 41. Global Lung Cancer Screening Software Market Share Forecast by Type (2027-2032)
Figure 42. Global Lung Cancer Screening Software Consumption Value Share by Application (2021-2026)
Figure 43. Global Lung Cancer Screening Software Market Share Forecast by Application (2027-2032)
Figure 44. North America Lung Cancer Screening Software Consumption Value Market Share by Type (2021-2032)
Figure 45. North America Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2032)
Figure 46. North America Lung Cancer Screening Software Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Lung Cancer Screening Software Consumption Value Market Share by Type (2021-2032)
Figure 51. Europe Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2032)
Figure 52. Europe Lung Cancer Screening Software Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 54. France Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Lung Cancer Screening Software Consumption Value Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Lung Cancer Screening Software Consumption Value Market Share by Region (2021-2032)
Figure 61. China Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 64. India Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Lung Cancer Screening Software Consumption Value Market Share by Type (2021-2032)
Figure 68. South America Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2032)
Figure 69. South America Lung Cancer Screening Software Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Lung Cancer Screening Software Consumption Value Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Lung Cancer Screening Software Consumption Value Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Lung Cancer Screening Software Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 77. UAE Lung Cancer Screening Software Consumption Value (2021-2032) & (USD Million)
Figure 78. Lung Cancer Screening Software Market Drivers
Figure 79. Lung Cancer Screening Software Market Restraints
Figure 80. Lung Cancer Screening Software Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Lung Cancer Screening Software Industrial Chain
Figure 83. Methodology
Figure 84. Research Process and Data Source
